# Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs

> **NCT04034862** · PHASE3 · COMPLETED · sponsor: **University of Liege** · enrollment: 36 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Treatment simplification (dolutegravir lamivudine)

## Key facts

- **NCT ID:** NCT04034862
- **Lead sponsor:** University of Liege
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-06-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034862, "Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04034862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*